Clinical case of Long-COVID complicated by the development of pneumocystis pneumonia in patient with follicular lymphoma
Year: 2025
Type: article
Study design: Case Report
Abstract: The COVID-19 pandemic has led to global consequences, including Long-COVID. This term is used to refer to the symptoms of a new coronavirus infection that last more than 4 weeks, but less than 12 weeks from the onset of the disease. The most common symptoms are shortness of breath, cough, and general weakness. The risk group for the long-term course of COVID-19 includes patients with immunodeficiency. One of the reasons for the long-term persistence of symptoms is the persistence of the virus in the body. However, in 30–40% of cases, the results of the SARS-CoV-2 test turn out to be negative, which makes it difficult to make a diagnosis. In addition, patients with immunodeficiency against Long-COVID may develop opportunistic infections caused by reactivated opportunistic microflora against the background of lymphopenia. The presented clinical example demonstrates a case of Long-COVID infection complicated by the development of pneumocystis pneumonia in a patient with follicular lymphoma. Timely diagnosis and initiation of specific treatment made it possible to stabilize the patient’s condition and prevent the fulminant course of pneumocystis infection.
Source: Journal Infectology
Authors: A. A. Demina, D. A. Kutsakina, N. A. Nikolaeva, O. O. Voronkova, D. A. Budanova, E. F. Rogova, M. V. Kozhevnikova, Yu. N. Belenkov
Institution: Sechenov University
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4414427790